NCT/Study#
NCT02861573 /
MK3475-365
Phase Ib/II Trial Of Pembrolizumab (MK-3475) Combination Therapies In Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
DISEASE GROUP:
Genito-Urinary
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
